Clinical Trial Update: A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma [NA]

View source ↗

Summary

A prospective feasibility study at MD Anderson to use circulating tumor DNA to tailor neoadjuvant chemotherapy for patients with colorectal or appendiceal adeno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Adenocarcinoma
• Colorectal Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Appendiceal Adenocarcinoma, Colorectal | NA | Status: RECRUITING